SEATTLE, July 22, 2021, (MEDGADGET) — Global Test Phantom Market Analysis
Overview
Test phantoms, also known as imaging phantoms, are specially designed items that are used in the area of medical imaging to test, evaluate, and calibrate a variety of imaging instruments. Drug trial phantoms are synthetic tissue-equivalent substances that are used to verify that methodologies for scanning the human body are functioning properly.
A test phantom is inexpensive and provides more trustworthy findings than human participants. CT test phantoms, mammography test phantoms, ultrasonic test phantoms, radiology test phantoms, and MRI test phantoms are all available on the market. Each test phantom type provides different information on the body area that is being investigated for damage or illness treatment. Recent advancements in test phantom methods offer a better non-invasive option for diagnosing chronic illnesses and the treatments linked with them.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2287
Drivers
The rising incidence of chronic illnesses such as HIV, TB, and cancer is projected to propel the global test phantom market to new heights. As per the World Health Organization’s important fact for 2018, cancer was the world’s second leading cause of mortality in 2015, with 8.8 million fatalities. Furthermore, medical imaging is a significant aspect of the healthcare sector since practically all diagnosis and treatments are dependent on the information offered by imaging techniques.
The global test phantom market is forecast to rise due to the increased usage of imaging methods in the healthcare industry. As per the National Health Services (UK) radiology dataset, about 41 million radiation therapy tests were reported in England in 2017, with 3.49 million imaging tests collected in January 2017. Radiographs were conducted 1.89 million times, followed by diagnostic ultrasonography (0.77 million), CT scan (0.40 million), and MRI (0.40 million) (0.28 million). Moreover, government support for improved imaging techniques is expected to boost growth of the global test phantom market significantly. The UK government invested US$ 27,327,000 in the University of Glasgow’s Imaging Center for Excellence (ICE) in 2014.
Restraints
The global test phantom market’s growth is projected to be hampered by the high maintenance costs associated with medical test phantoms.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2287
Regional Analysis
Over the forecast period, North America dominated the global test phantom market. This is due to the region’s growing research and development activity in imaging technology. Furthermore, the market is forecast to develop due to an increase in the utilization of clinical testing by healthcare institutions. As per the National Science and Technology Council’s 2017 report, the U.S. did 79 million CT scans, 39 million MRI scans, and 1.7 million PET scans in 2015.
Additionally, due to the rising frequency of chronic illnesses in the area, Asia Pacific is estimated to have considerable growth in the global test phantom market, followed by Europe. As per a World Health Organization research from 2011, the Asia Pacific region accounts for roughly 33% of maternal disorders, 35% of malnutrition, 27% of parasitic and infectious disorders, 30% of bacterial illnesses, and 37% of perinatal illnesses in the worldwide burden.
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/2287
Competitive Landscape
Key companies contributing in the global test phantom market are The Phantom Laboratory, Pro-Project, Capintec, Standard Imaging, Biodex Medical Systems, IBA, Radiology Support Devices, Fluke Corporation, 3-Dmed, Sun Nuclear Corporation, Modus Medical Devices, Kyoto Kagaku Co., Ltd, CIRS, Carville, and RaySafe.
To maintain their dominating position in the market, key companies are focusing on market tactics such as cooperation, acquisitions, and new product launches. Kyoto Kagaku Co., Ltd introduced the Female Pelvis Ultrasound Phantom US-14a and US-14b in 2014, with characteristics such as precise cerebral anatomy that mimics the human brain.
Table of Content
Global Test Phantom Market Research Report
Section 1: Global Test Phantom Industry Overview
Section 2: Global Economic Impact on Test Phantom Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Test Phantom Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Test Phantom Market Forecast
Have a Look at Related Research Insights:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837